Cargando…
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further considerat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279915/ https://www.ncbi.nlm.nih.gov/pubmed/35847898 http://dx.doi.org/10.3389/fonc.2022.902820 |
_version_ | 1784746512465526784 |
---|---|
author | Liu, Sha Huang, Fang Ru, Guoqing Wang, Yigang Zhang, Bixiang Chen, Xiaoping Chu, Liang |
author_facet | Liu, Sha Huang, Fang Ru, Guoqing Wang, Yigang Zhang, Bixiang Chen, Xiaoping Chu, Liang |
author_sort | Liu, Sha |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective in vivo model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments. |
format | Online Article Text |
id | pubmed-9279915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92799152022-07-15 Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application Liu, Sha Huang, Fang Ru, Guoqing Wang, Yigang Zhang, Bixiang Chen, Xiaoping Chu, Liang Front Oncol Oncology Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective in vivo model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9279915/ /pubmed/35847898 http://dx.doi.org/10.3389/fonc.2022.902820 Text en Copyright © 2022 Liu, Huang, Ru, Wang, Zhang, Chen and Chu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Liu, Sha Huang, Fang Ru, Guoqing Wang, Yigang Zhang, Bixiang Chen, Xiaoping Chu, Liang Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title_full | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title_fullStr | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title_full_unstemmed | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title_short | Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application |
title_sort | mouse models of hepatocellular carcinoma: classification, advancement, and application |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279915/ https://www.ncbi.nlm.nih.gov/pubmed/35847898 http://dx.doi.org/10.3389/fonc.2022.902820 |
work_keys_str_mv | AT liusha mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT huangfang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT ruguoqing mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT wangyigang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT zhangbixiang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT chenxiaoping mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication AT chuliang mousemodelsofhepatocellularcarcinomaclassificationadvancementandapplication |